Clinical trial · Interventional
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The uptake of vaccines for Human Papillomavirus (HPV) in the U.S. is far below recommended levels, particularly for adolescent boys and especially among minority families. Proposed here is a mobile web application ("mobile web app") for personal computers, smart phones, and tablet computers that will accurately inform parents and adolescent boys about the HPV vaccination and address unique concerns about its safety and effectiveness for boys. The BoyVac mobile web app will be evaluated for its ability to improve vaccine outcomes in a randomized efficacy trial with parents and adolescent boys aged 11-13 years.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| HPV | — | UNRESOLVED | — |
| Human Papillomavirus Virus | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Usual Customary Care Group | Behavioral | — | UNRESOLVED |
| Web App Intervention Group | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Web App Intervention Group
- description
- The BoyVac mobile web app will be evaluated in a pair-matched group-randomized pretest-posttest controlled design. In Year 2, 30 clinics in New Mexico will be pair-matched and one member of each pair will be randomized to the intervention (mobile web app) or a usual and customary (UC) HPV vaccine adoption procedures comparison group. Clinics will be paired based on similarities in patient demographic (ethnicity and % Medicaid patients) and location (urban and rural).
- interventionNames
- Behavioral: Web App Intervention Group
- type
- ACTIVE_COMPARATOR
- label
- Usual Customary Care Group
- description
- Currently in pediatric clinics in New Mexico, the HPV vaccines are offered to parents and adolescents as part of annual well-child checkups. Typically for boys aged 11-13, parents initiate this checkup as part of a back-to-school activity. As part of the well-child checkup, clinic staff (physician, physician assistant and/or nurse) talk with parents and adolescents about the recommendation that their sons or daughters receive the HPV vaccination. Well-child pediatric visits to promote good health and development are recommended for all children from infancy through adolescence by the American Academy of Pediatrics.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 11 Years
Show eligibility criteria text
Inclusion Criteria: Adolescent boys: 1. being male 2. being 11-13 years old 3. being a patient at a participating University of New Mexico (UNM) Hospital's Envision pediatric practice 4. parental consent for testing, and 5. child assent for testing Parents/Guardians: 1. being a parent/guardian of an eligible and participating 11-13 year old boy 2. demonstrated ability to comprehend study requirements, and 3. providing informed consent for oneself and assent for their youth's participation Exclusion Criteria: Adolescent boys: 1. another immediate family member is participating in the project (i.e., a sibling) 2. the participant has already received any or all doses for the HPV vaccine, or 3. the participant refuses to assent. Parents/Guardians: 1. under the age of 18, or 2. another immediate family member is participating in the project (i.e., another parent).
References
Publications (0)
Data not yet available